LUPIN Intraday Analysis...

LUPIN Share Price

Open 1492.10 Change Price %
High 1510.75 1 Day 2.90 0.19
Low 1490.50 1 Week -24.85 -1.63
Close 1496.90 1 Month 27.50 1.87
Volume 451242 1 Year -205.65 -12.08
52 Week High 1911.90
52 Week Low 1280.00
LUPIN Important Levels
Resistance 2 1515.67
Resistance 1 1507.94
Pivot 1499.38
Support 1 1485.86
Support 2 1478.13
NSE INDIA Most Active Stocks
JPASSOCIAT 10.20 5.15%
SUZLON 15.70 0.64%
JINDALSTEL 80.20 3.48%
ADANIPOWER 37.85 2.30%
HINDALCO 177.00 3.48%
VEDL 244.40 3.52%
GMRINFRA 12.55 0.00%
BHEL 132.40 3.48%
POWERGRID 198.45 0.35%
NHPC 29.80 -0.50%
More..
NSE INDIA Top Gainers Stocks
RASOYPR 0.20 33.33%
FMNL 45.00 20.00%
INDOTHAI 25.05 19.86%
HOTELRUGBY 4.60 19.48%
OILCOUNTUB 52.05 17.89%
PANACEABIO 148.30 16.59%
ELGIRUBCO 55.95 15.96%
TRIL 437.90 15.42%
WEIZFOREX 244.90 14.81%
JINDCOT 16.85 14.63%
More..
NSE INDIA Top Losers Stocks
VKSPL 0.10 -33.33%
FCSSOFT 0.30 -14.29%
SPYL 1.00 -13.04%
NAKODA 0.40 -11.11%
UNITEDTEA 303.95 -8.55%
AGARIND 332.80 -7.14%
ASIL 0.70 -6.67%
CELESTIAL 21.30 -6.17%
KRIDHANINF 57.75 -6.02%
SUNDARAM 4.05 -5.81%
More..

Lupin Limited (NSE: LUPIN)

LUPIN Technical Analysis 2
As on 18th Jan 2017 LUPIN Share Price closed @ 1496.90 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1558.50 & Buy for SHORT-TERM with Stoploss of 1481.10 we also expect STOCK to react on Following IMPORTANT LEVELS.
LUPIN Target for January
1st Target up-side 1569.08
2nd Target up-side 1626.65
3rd Target up-side 1684.22
1st Target down-side 1404.82
2nd Target down-side 1347.25
3rd Target down-side 1289.68
LUPIN Synopsis Technicals View
50 Day EMA N/A (Short Term)
N/A
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
WILLIAM %R (14) N/A N/A
ADX (14) N/A N/A
PSAR N/A N/A
10 Day Avg Volume N/A
LUPIN Other Details
Segment EQ
Market Capital 167129956352.00
Sector Healthcare
Industry Drugs - Generic
Offical website http://www.lupinworld.com
LUPIN Address
LUPIN
Laxmi Towers, B Wing
Bandra Kurla Complex
Mumbai, 400051
India
Phone: 91 22 6640 2222
Fax: 91 22 6640 2130
LUPIN Latest News
Interactive Technical Analysis Chart Lupin Limited ( LUPIN NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Lupin Limited
LUPIN Business Profile
Lupin is in the Pharmaceuticals sector.Lupin was founded in 1968. Lupin Limited is a transnational pharmaceutical company based in Mumbai. It is the 2nd largest Indian pharma company by market capitalization; the 14th largest generic pharmaceutical company globally and; the 5th largest generic pharmaceutical company in the US by prescription-led market share.It has the distinction of being the fastest growing generic pharmaceutical player in the two largest pharmaceutical markets of the world – the US and Japan;and is the 5th largest and the fastest growing generic pharmaceutical player in South Africa. The current market capitalisation stands at Rs 38,843.21 crore.The company has reported a consolidated sales of Rs 2667.87 crore and a Net Profit of Rs 417.28 crore for the quarter ended Sep 2013. The company management includes Desh Bandhu Gupta - Chairman, Kamal K Sharma - Managing Director, M D Gupta - Executive Director, Nilesh Gupta - Executive Director, Vinita Gupta - Director, Vijay Kelkar - Director, Richard Zahn - Director, R A Shah - Director, K U Mada - Director, Dileep C Choksi - Additional Director. It is listed on the BSE with a BSE Code of 500257 and the NSE with an NSE Code of LUPIN.